4//SEC Filing
McAvoy David R. 4
Accession 0001062993-20-004584
CIK 0000819050other
Filed
Sep 20, 8:00 PM ET
Accepted
Sep 21, 4:19 PM ET
Size
6.5 KB
Accession
0001062993-20-004584
Insider Transaction Report
Form 4
McAvoy David R.
General Counsel
Transactions
- Purchase
Common Stock
2020-09-18$0.83/sh+16,526$13,713→ 75,883 total - Purchase
Common Stock
2020-09-18$0.84/sh+6,000$5,039→ 6,000 total(indirect: By Spouse)
Footnotes (1)
- [F1]Represents the purchase of 16,526 shares in multiple transactions, ranging in price from $0.8224 to $0.8429 per share, resulting in a weighted average purchase price of $0.8298. The reporting person will provide, upon request by the SEC staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares purchased at each price within the range.
Issuer
Brickell Biotech, Inc.
CIK 0000819050
Entity typeother
Related Parties
1- filerCIK 0001758842
Filing Metadata
- Form type
- 4
- Filed
- Sep 20, 8:00 PM ET
- Accepted
- Sep 21, 4:19 PM ET
- Size
- 6.5 KB